Xencor, INC. SEVERANCE AGREEMENTSeverance Agreement • August 3rd, 2016 • Xencor Inc • Pharmaceutical preparations • California
This Severance Agreement (the “Agreement”) is dated as of May 26, 2016 (the “Effective Date”), by and between Bassil I. Dahiyat, Ph.D. (“Executive”) and Xencor, Inc., a Delaware corporation (the “Company”). This Agreement is intended to provide Executive with certain severance and change in control benefits as described herein.
COLLABORATION AND LICENSE AGREEMENT by and between XENCOR, INC. and NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.Collaboration and License Agreement • August 3rd, 2016 • Xencor Inc • Pharmaceutical preparations • New York
THIS COLLABORATION AND LICENSE AGREEMENT (this “Agreement”), entered into as of June 26, 2016 (the “Effective Date”), is entered into by and between Xencor, Inc., a corporation organized and existing under the Laws of the State of Delaware (“Xencor”), and Novartis Institutes for BioMedical Research, Inc., a corporation organized and existing under the Laws of the State of Delaware (“Novartis”). Xencor and Novartis are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.
